Selection and evaluation of the immunogenicity of protective antigen mutants as anthrax vaccine candidates.
about
Anthrax vaccination strategiesResidue histidine 669 is essential for the catalytic activity of Bacillus anthracis lethal factor.A chimeric protein that functions as both an anthrax dual-target antitoxin and a trivalent vaccine.Combination of two candidate subunit vaccine antigens elicits protective immunity to ricin and anthrax toxin in miceDermatan sulfate interacts with dead cells and regulates CD5(+) B-cell fate: implications for a key role in autoimmunityIn vitro and in vivo activities of recombinant anthrax protective antigen co-expressed with thioredoxin in Escherichia coli.Immunization with a Recombinant, Pseudomonas fluorescens-Expressed, Mutant Form of Bacillus anthracis-Derived Protective Antigen Protects Rabbits from Anthrax InfectionInvolvement of the pagR gene of pXO2 in anthrax pathogenesis.Investigation of new dominant-negative inhibitors of anthrax protective antigen mutants for use in therapy and vaccination.Novel vaccines: bridging research, development and production.Role of the Antigen Capture Pathway in the Induction of a Neutralizing Antibody Response to Anthrax Protective Antigen.
P2860
Q28392248-77A84E6A-79D6-4F0D-9B88-251CCA408E93Q34192622-9EEC0367-B3B0-4D6B-9A2E-103AD9A4729BQ34289944-D2098C1A-E184-452A-90B9-6FE4E1FF2443Q34759081-A787CBC3-E35B-4C42-9862-4CC35B2C8723Q34839450-97807121-CD58-410A-B795-EA79CEF406B2Q34861411-C45BF5B8-99EF-4AEC-9048-C7FAC86094C8Q35710981-E96003B6-1573-4C19-AEA6-16C8EDD8C1CEQ37057257-1C82D439-EAAB-4C02-9139-8C1866D3AC61Q37355950-A844CAE3-A23F-41E4-A0F8-B9520D7567A5Q47886568-ECECE0C9-3161-465B-9159-0D52337EE788Q52682459-2D77A80E-83D0-4C71-8D68-A15B1428F8B5
P2860
Selection and evaluation of the immunogenicity of protective antigen mutants as anthrax vaccine candidates.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Selection and evaluation of th ...... as anthrax vaccine candidates.
@ast
Selection and evaluation of th ...... as anthrax vaccine candidates.
@en
type
label
Selection and evaluation of th ...... as anthrax vaccine candidates.
@ast
Selection and evaluation of th ...... as anthrax vaccine candidates.
@en
prefLabel
Selection and evaluation of th ...... as anthrax vaccine candidates.
@ast
Selection and evaluation of th ...... as anthrax vaccine candidates.
@en
P2093
P2860
P1433
P1476
Selection and evaluation of th ...... as anthrax vaccine candidates.
@en
P2093
Emre Basar
Julia Y Wang
Michael H Roehrl
P2860
P304
P356
10.1016/J.VACCINE.2007.11.087
P407
P577
2007-12-26T00:00:00Z